VCBeat Health Contact Us
Home Mangoceuticals Announces Partnership with Eli Lilly and Novo Nordisk to Distribute GLP-1 Weight Loss Medications via Telehealth Platforms

Mangoceuticals Announces Partnership with Eli Lilly and Novo Nordisk to Distribute GLP-1 Weight Loss Medications via Telehealth Platforms

Nov 13, 2025 21:37 CST Updated 21:37
MANGOCEUTICALS

Male Health Telemedicine Platform

Eli Lilly

Global Pharmaceutical R&D and Production Company

Novo Nordisk

Insulin Developer and Manufacturer

Gelonghui November 13 | Remote healthcare company MANGOCEUTICALS announced that it has partnered with Eli Lilly and Novo Nordisk to sell the two pharmaceutical companies' weight-loss drugs through its platform.